BioTuesdays
MaxCyte Logo

MaxCyte appoints Ali Soleymannezhad as CCO

MaxCyte (NASDAQ:MXCT; LSE:MXCT) has appointed Ali Soleymannezhad as chief commercial officer, effective September 11, 2024. Prior to this role, Mr. Soleymannezhad served as executive vice president of bioprocessing at...

Sernova appoints David Patterson Ph.D. to BOD

Sernova Corp. (TSX:SVA) has announced the appointment of David Patterson, Ph.D., to its board of directors, effective immediately. “I am pleased to have been able to attract David Paterson’s significant talent to...

MOBILion appoints Rohit Khanna to BOD

Closely-held MOBILion Systems has announced the appointment of seasoned life sciences executive, Rohit Khanna, Ph.D., to its board, effective immediately. Dr. Khanna co-founded software engineering firm Dynamic...

ANEW Medical appoints Jeffrey LeBlanc as CFO

ANEW Medical (NASDAQ:WENA) announced the appointment of Jeffrey LeBlanc as its new CFO, succeeding interim CFO, Edward Cong Wang, the former CFO of Redwoods Acquisition, which ANEW merged with. ANEW’s portfolio includes...

Cantargia Logo

Cantargia names Ton Berkien as CBO

Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) announced the recruitment of Ton Berkien as Chief Business Officer effective October 1. Mr. Berkien joins the management team at Cantargia with approximately 30 years of...

Mati promotes Chris Muller to COO

Closely-held Mati Therapeutics named Chris Muller as COO, effective immediately. Most recently Mati’s CCO, Mr. Muller’s expanded responsibilities include overseeing all operating activities; and preparing for and...

Enzo Logo

Enzo Biochem names Kara Cannon as interim CEO

Enzo Biochem (NYSE:ENZ) appointed its chief operating officer, Kara Cannon, to be interim CEO after Hamid Erfanian, former CEO, left the company, effective Sept. 5. Mr. Erfanian led the company through the sale of Enzo...

Sernova-Logo

Sernova names Cynthia Pussinen as CEO

Sernova (TSX:SVA; OTCQB:SEOVF; FSE/XETRA:PSH) appointed Cynthia Pussinen as CEO and a member of the board, succeeding Dr. Philip Toleikis, who will serve as chief technology officer. Ms. Pussinen’s expertise spans...

Hygieia-Logo

Zoe Heineman joins Hygieia as VP of BD

Closely-held Hygieia, a provider of digital therapeutics for insulin management, hired Zoe Heineman as VP of business development. Ms. Heineman brings more than 30 years of expertise in strategic leadership, operations...